Atezolizumab,Cabozantinib
Roche
['atezo', 'rcc,(-irccs),(-srcc),(-urcc)', 'renal,(-adrenal)', 'cabozantinib']
cabozantinib/atezolizumab does not improve pfs or os in advanced renal cell carcinoma. #urology #urologist #rcc #kidneycancer #asco23 
The Leading News Source for Urologists - https://t.co/hDKngB4IyE
Expert clinical analysis. Practice advice. Policy perspectives.